Valérie Gounant

发表

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial

Olivier Molinier, Franck Morin, Christian Creveuil, 2016, The Lancet.

Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as a biomarker for the effect of PTK787/ZK 222584 (PTK/ZK) as second-line mono-therapy in patients with stage IIIB or stage IV non-small cell lung cancer (NSCLC)

Mark A. Horsfield, Bruno Morgan, Thomas Gauler, 2007 .